Universität zu Köln

Journal Article

Czauderna, Carolin, Poplawski, Alicia, O'Rourke, Colm J., Castven, Darko, Perez-Aguilar, Benjamin, Becker, Diana, Heilmann-Heimbach, Stephanie, Odenthal, Margarete ORCID: 0000-0002-2424-0960, Amer, Wafa, Schmiel, Marcel, Drebber, Uta, Binder, Harald, Ridder, Dirk A., Schindeldecker, Mario ORCID: 0000-0003-4843-7992, Straub, Beate K., Galle, Peter R., Andersen, Jesper B., Thorgeirsson, Snorri S., Park, Young Nyun and Marquardt, Jens U. (2021). Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis. JCI Insight, 6 (17). ANN ARBOR: AMER SOC CLINICAL INVESTIGATION INC. ISSN 2379-3708

El-Khoueiry, Anthony B., Kim, Richard D., Harris, William P., Sung, Max W., Waldschmidt, Dirk, Iqbal, Syma, Zhang, Xiaojing (Amily), Nakajima, Keiko and Galle, Peter R. (2020). Phase Ib study of regorafenib (REG) plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC). J. Clin. Oncol., 38 (4). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

El-Khoueiry, Anthony B., Kim, Richard D., Harris, William Proctor, Sung, Max W., Waldschmidt, Dirk, Cabrera, Roniel, Garosi, Vittorio Luigi, Zebger-Gong, Hong, Brennan, Barbara J., Wang, Ying A., Mueller, Udo, Ishida, Tatiane Cristine and Galle, Peter R. (2021). Updated results of a phase 1b study of regorafenib (REG) 80 mg/day or 120 mg/day plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC). J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755

Engelmann, Cornelius, Herber, Adam, Franke, Annegret, Bruns, Tony ORCID: 0000-0002-5576-6914, Reuken, Philipp, Schiefke, Ingolf, Zipprich, Alexander, Zeuzem, Stefan, Goeser, Tobias, Canbay, Ali, Berg, Christoph, Trebicka, Jonel, Uschner, Frank E., Chang, Johannes, Mueller, Tobias ORCID: 0000-0003-3426-5421, Aehling, Niklas, Schmelzle, Moritz, Splith, Katrin, Lammert, Frank, Lange, Christian M., Sarrazin, Christoph, Trautwein, Christian, Manns, Michael, Haeussinger, Dieter, Pfeiffenberger, Jan, Galle, Peter R., Schmiedeknecht, Anett and Berg, Thomas (2021). Granulocyte-colony stimulating factor (G-CSF) to treat acute-on- chronic liver failure: A multicenter randomized trial (GRAFT study). J. Hepatol., 75 (6). S. 1346 - 1356. AMSTERDAM: ELSEVIER. ISSN 1600-0641

Hahn, Felix, Mueller, Lukas, Maehringer-Kunz, Aline, Tanyildizi, Yasemin, dos Santos, Daniel Pinto, Dueber, Christoph, Galle, Peter R., Weinmann, Arndt and Kloeckner, Roman ORCID: 0000-0001-5492-4792 (2020). Distant Metastases in Patients with Intrahepatic Cholangiocarcinoma: Does Location Matter? A Retrospective Analysis of 370 Patients. J. Oncol., 2020. LONDON: HINDAWI LTD. ISSN 1687-8469

Hoffman, Arthur, Korczynski, Oliver, Tresch, Achim, Hansen, Torsten, Rahman, Farreed, Goetz, Martin, Murthy, Sanyaj, Galle, Peter R. and Kiesslich, Ralf (2014). Acetic acid compared with i-scan imaging for detecting Barrett's esophagus: a randomized, comparative trial. Gastrointest. Endosc., 79 (1). S. 46 - 55. NEW YORK: MOSBY-ELSEVIER. ISSN 1097-6779

Kim, Richard D., Harris, William P., Sung, Max W., Waldschmidt, Dirk Thomas, Cabrera, Roniel, Mueller, Udo, Menezes, Flavia, Ishida, Tatiane, Galle, Peter R. and El-Khoueiry, Anthony B. (2021). Results of a phase Ib study of regorafenib (REG) 80 mg/day plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC). J. Clin. Oncol., 39 (3). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755

Maehringer-Kunz, Aline, Meyer, Franziska I., Hahn, Felix, Mueller, Lukas, Dueber, Christoph, Pinto Dos Santos, Daniel, Galle, Peter R., Weinmann, Arndt ORCID: 0000-0003-1198-1716, Kloeckner, Roman ORCID: 0000-0001-5492-4792 and Schotten, Sebastian (2021). Hepatic vein tumor thrombosis in patients with hepatocellular carcinoma: Prevalence and clinical significance. United European Gastroenterol. J., 9 (5). S. 590 - 598. THOUSAND OAKS: SAGE PUBLICATIONS INC. ISSN 2050-6414

Maehringer-Kunz, Aline, Steinle, Verena, Dueber, Christoph, Weinmann, Arndt ORCID: 0000-0003-1198-1716, Koch, Sandra, Schmidtmann, Irene, Schotten, Sebastian ORCID: 0000-0003-3359-0732, Hinrichs, Jan B., Graafen, Dirk, dos Santos, Daniel Pinto, Galle, Peter R. and Kloeckner, Roman ORCID: 0000-0001-5492-4792 (2019). Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse? Liver Int., 39 (2). S. 324 - 332. HOBOKEN: WILEY. ISSN 1478-3231

Maehringer-Kunz, Aline, Wagner, Franziska, Hahn, Felix, Weinmann, Arndt, Brodehl, Sebastian, Schotten, Sebastian, Hinrichs, Jan B., Dueber, Christoph, Galle, Peter R., dos Santos, Daniel Pinto and Kloeckner, Roman (2020). Predicting survival after transarterial chemoembolization for hepatocellular carcinoma using a neural network: A Pilot Study. Liver Int., 40 (3). S. 694 - 704. HOBOKEN: WILEY. ISSN 1478-3231

Mueller, Lukas, Hahn, Felix, Maehringer-Kunz, Aline, Stoehr, Fabian, Gairing, Simon J., Foerster, Friedrich, Weinmann, Arndt ORCID: 0000-0003-1198-1716, Galle, Peter R., Mittler, Jens, Pinto dos Santos, Daniel, Pitton, Michael B., Dueber, Christoph and Kloeckner, Roman (2021). Immunonutritive Scoring in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Prognostic Nutritional Index or Controlling Nutritional Status Score? Front. Oncol., 11. LAUSANNE: FRONTIERS MEDIA SA. ISSN 2234-943X

Reissig, Sonja, Tang, Yilang, Nikolaev, Alexei, Gerlach, Katharina, Wolf, Christine, Davari, Kathrin, Gallus, Christian, Masri, Joumana, Mufazalov, Ilgiz A., Neurath, Markus F., Wunderlich, F. Thomas, Schattenberg, Joern M., Galle, Peter R., Weigmann, Benno, Waisman, Ari, Glasmacher, Elke and Hoevelmeyer, Nadine (2017). Elevated levels of Bcl-3 inhibits Treg development and function resulting in spontaneous colitis. Nat. Commun., 8. LONDON: NATURE PUBLISHING GROUP. ISSN 2041-1723

Vollmar, Johanna, Lautem, Anja, Closs, Ellen ORCID: 0000-0002-9505-2289, Schuppan, Detlef, Kim, Yong Ook, Grimm, Daniel, Marquardt, Jens U., Fuchs, Peter, Straub, Beate K., Schad, Arno, Grundemann, Dirk, Schattenberg, Jorn M. ORCID: 0000-0002-4224-4703, Gehrke, Nadine, Worns, Marcus A., Baumgart, Jan, Galle, Peter R. and Zimmermann, Tim (2017). Loss of organic cation transporter 3 (Oct3) leads to enhanced proliferation and hepatocarcinogenesis. Oncotarget, 8 (70). S. 115667 - 115681. ORCHARD PARK: IMPACT JOURNALS LLC. ISSN 1949-2553

Weinmann, Arndt, Steinle, Verena, Koch, Sandra, dos Santos, Daniel Pinto, Marquardt, Jens Uwe, Sprinzl, Martin, Lang, Hauke, Duber, Christoph, Galle, Peter R., Woerns, Marcus A. and Kloeckner, Roman (2017). Portal vein infiltration in patients with hepatocellular carcinoma: The relevance of correct classification. J. Clin. Oncol., 35. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755